The Venture Codex Logo

The Venture Codex

Access Biotechnology

40 West 57th Street 28th Floor, New York, NY, 10019, United States

Overview

Life science investment firm focusing on transformative therapies.

Founded

1986

Deals · 12mo

2

Links

WebsiteLinkedIn

Stage focus

Series A
Series B

Geographic focus

Denmark
United States

Sector focus

Biopharma
Biotechnology
Health Care
Life Science

Investment portfolio

27rounds
NAMEDATESIZE
Matchpoint Therapeutics
Oct 2026Participated
$150 MSeries B
Hemab
Oct 2025Participated
$157 MSeries C
Draig Therapeutics
Jun 2025Led
$140 MSeries A
Latigo Biotherapeutics
Mar 2025Participated
$150 MSeries B
Halda Therapeutics
Aug 2024Participated
$126 MSeries B
GRO Biosciences
Jul 2024Led
$60 MSeries B
Santa Ana Bio
Jun 2024Participated
$168 MSeries B
Zura Bio
Apr 2024Led
$113 MSeries A
Areteia Therapeutics
Feb 2024Participated
$75 MSeries A
Mariana Oncology
Sep 2023Participated
$175 MSeries B
Upstream Bio
Jun 2023Participated
$200 MSeries B
Hemab
Feb 2023Led
$135 MSeries B
Matchpoint Therapeutics
Oct 2026Participated
$150 MSeries B
Hemab
Oct 2025Participated
$157 MSeries C
Draig Therapeutics
Jun 2025Led
$140 MSeries A
Latigo Biotherapeutics
Mar 2025Participated
$150 MSeries B
Halda Therapeutics
Aug 2024Participated
$126 MSeries B
GRO Biosciences
Jul 2024Led
$60 MSeries B
Santa Ana Bio
Jun 2024Participated
$168 MSeries B
Zura Bio
Apr 2024Led
$113 MSeries A
Areteia Therapeutics
Feb 2024Participated
$75 MSeries A
Mariana Oncology
Sep 2023Participated
$175 MSeries B
Upstream Bio
Jun 2023Participated
$200 MSeries B
Hemab
Feb 2023Led
$135 MSeries B
27
Items
...
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Access Biotechnology: 27 funding rounds are recorded in the selected participation categories.All available history.
Access Biotechnology: 27 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Series A35
Series B410
Series C+11
Other Equity03

Monthly Deal Activity

Access Biotechnology: 27 deals are recorded across 88 months.All available history.
Access Biotechnology: 27 deals are recorded across 88 months. All available history
MonthDeals
Jul '191
Aug '190
Sep '191
Oct '191
Nov '190
Dec '190
Jan '200
Feb '200
Mar '200
Apr '201
May '201
Jun '200
Jul '200
Aug '200
Sep '200
Oct '200
Nov '200
Dec '200
Jan '210
Feb '211
Mar '211
Apr '211
May '211
Jun '210
Jul '211
Aug '210
Sep '211
Oct '210
Nov '210
Dec '210
Jan '220
Feb '220
Mar '220
Apr '220
May '220
Jun '221
Jul '221
Aug '220
Sep '222
Oct '220
Nov '220
Dec '220
Jan '230
Feb '231
Mar '230
Apr '230
May '230
Jun '231
Jul '230
Aug '230
Sep '231
Oct '230
Nov '230
Dec '230
Jan '240
Feb '241
Mar '240
Apr '241
May '240
Jun '241
Jul '241
Aug '241
Sep '240
Oct '240
Nov '240
Dec '240
Jan '250
Feb '250
Mar '251
Apr '250
May '250
Jun '251
Jul '250
Aug '250
Sep '250
Oct '251
Nov '250
Dec '250
Jan '260
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '260
Oct '261

Sector Breakdown

Access Biotechnology: Health & Life Sciences is the largest displayed sector by deal count (27 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Access Biotechnology: Health & Life Sciences is the largest displayed sector by deal count (27 deals). All available history
SectorDeals
Health & Life Sciences27
Space & Frontier Tech1

Deal Size Distribution

Access Biotechnology: 27 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Access Biotechnology: 27 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M0
$5M-$10M0
$10M-$25M0
$25M-$50M1
$50M-$100M8
$100M-$250M16
$250M-$500M2
$500M-$1B0
$1B+0

Deals By Geography

Access Biotechnology: United States has the largest recorded deal count among the displayed regions (24 deals).All available history.

Top 2 of 2 regions; European countries are grouped as Europe.

Access Biotechnology: United States has the largest recorded deal count among the displayed regions (24 deals). All available history
RegionDeals
United States24
Europe3
Access Biotechnology: 20 co-investors are shown, with RA Capital Management sharing 11 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Access Biotechnology: 20 co-investors are shown, with RA Capital Management sharing 11 recorded deals. All available history
Co-investorShared deals
RA Capital Management11
Atlas Venture9
OrbiMed6
Deep Track Capital5
Bain Capital Life Sciences4
Boxer Capital4
Canaan Partners4
Novo Holdings4
Rock Springs Capital4
Surveyor Capital4
BVF Partners3
Decheng Capital3
Google Ventures3
Intermediate Capital Group3
Invus3
Janus Henderson Investors3
Logos Capital3
Samsara BioCapital3
Sanofi Ventures3
SR One3

Investment Strategy

Access Biotechnology: Led accounts for 30% and participating for 70% of round participation.All available history.
Access Biotechnology: Led accounts for 30% and participating for 70% of round participation. All available history
CategoryDeals (count)Share (%)
Led830%
Participating1970%
Access Biotechnology: Single-lead accounts for 63% and co-led for 38% of lead dynamics.All available history.
Access Biotechnology: Single-lead accounts for 63% and co-led for 38% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead563%
Co-led338%

Team

Christine Borowski

Senior Associate

Dan Becker

Principal

Jeffrey Ives

Advisor

Liam Ratcliffe

Head of Biotechnology